Posted by & filed under Company Analysis, Governments & Regulators, Growth & Valuation, Industry Analysis, Management Issues.

Description: Shares of Merck & Co. MRK,  tumbled 9.5% in midday trading Friday, putting them on track to suffer the biggest one-day drop since January 2005, after Pfizer Inc. PFE,  released data on a pill to treat COVID-19 that showed greater efficacy than Merck’s.


Date: Nov 05, 2021


Questions for discussion:

  • What does the article say to investors who are invested in the pharmaceutical firms fighting Covid?
  • What would you advise investors do to mitigate risk in this field?

Leave a Reply

Your email address will not be published. Required fields are marked *